Relation with HOMA-IR and Thyroid Hormones in Obese Turkish Women with Metabolic Syndrome

Overview

Journal Eat Weight Disord

Publisher Springer

Date 2012 Jul 4

PMID 22751273

Citations 10

Authors

S Topsakal

E Yerlikaya

F Akin

B Kaptanoglu

T Erurker

Affiliations

Soon will be listed here.

Abstract

The aim of this study was to investigate the relationship between insulin resistance and thyroid function in obese pre- and postmenopausal women with or without metabolic syndrome (MetS). 141 obese women were divided into two groups, HOMA-IR<2.7 and HOMA-IR>2.7, to evaluate relation with HOMA-IR and fatness, hormone and blood parameters. They were then divided into four groups as pre- and postmenopausal with or without MetS. Various fatness, hormone and blood parameters were examined. Statistically significant difference was found in weight, body mass index (BMI), waist circumference, fat%, fasting insulin, TSH, FT3, FT4, FSH, Anti-microsomal antibody (ANTIM) and triglycerides levels in HOMA-IR<2.7 and HOMA-IR>2.7 obese Turkish women. This study showed that age, weight, BMI, waist circumference, fat%, fasting insulin, FT3, ANTIM, FSH, LH, total cholesterol, triglycerides, HDL, HOMA-IR, systolic and diastolic blood pressure levels were related in preand post menopausal status in obese women with or without MetS. Obesity may influence the levels of thyroid hormones and increases the risk of MetS in women. Postmenopausal status with MetS is associated with an increased TSH, FT3 and FT4 levels and HOMA-IR in obese women. Strong relation was observed with MetS and TSH and FT3 levels.

Citing Articles

Alterations in Biomarkers Associated with Cardiovascular Health and Obesity with Short-Term Lifestyle Changes in Overweight Women: The Role of Exercise and Diet.

Sengun N, Pala R, Cinar V, Akbulut T, Larion A, Padulo J Medicina (Kaunas). 2025; 60(12.

PMID: 39768899 PMC: 11727739. DOI: 10.3390/medicina60122019.

EVALUATION OF THE RELATIONSHIP BETWEEN MEDICAL NUTRITION TREATMENT, PENTRAXIN-3, HSCRP AND BODY COMPOSITION ANALYSIS IN TYPE 2 DIABETIC PATIENTS.

Duran R, Marakoglu K, Vatansev H, Kizmaz M, Saracligil B, Aybatti E Acta Endocrinol (Buchar). 2023; 19(2):169-177.

PMID: 37908879 PMC: 10614593. DOI: 10.4183/aeb.2023.169.

Elevated Free Thyroxine Levels Might Alter the Effect of the Lipid Profile on Insulin Resistance in Type 2 Diabetes Mellitus.

Lee Y, Yang T, Lin Y, Hsieh Y Diagnostics (Basel). 2023; 13(16).

PMID: 37627914 PMC: 10453194. DOI: 10.3390/diagnostics13162656.

Predictive Effects of FT3/FT4 on Diabetic Kidney Disease: An Exploratory Study on Hospitalized Euthyroid Patients with T2DM in China.

Zhao X, Sun J, Xin S, Zhang X Biomedicines. 2023; 11(8).

PMID: 37626708 PMC: 10452238. DOI: 10.3390/biomedicines11082211.

Metabolic Syndrome and Subclinical Hypothyroidism: A Type 2 Diabetes-Dependent Association.

Bermudez V, Salazar J, Anez R, Rojas M, Estrella V, Ordonez M J Thyroid Res. 2018; 2018:8251076.

PMID: 30151097 PMC: 6087593. DOI: 10.1155/2018/8251076.

References

Tagliaferri M, Berselli M, Calo G, Minocci A, Savia G, Petroni M . Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile. Obes Res. 2001; 9(3):196-201. DOI: 10.1038/oby.2001.21. View

Lukanova A, Lundin E, Zeleniuch-Jacquotte A, Muti P, MURE A, Rinaldi S . Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur J Endocrinol. 2004; 150(2):161-71. DOI: 10.1530/eje.0.1500161. View

Poehlman E, Toth M, Gardner A . Changes in energy balance and body composition at menopause: a controlled longitudinal study. Ann Intern Med. 1995; 123(9):673-5. DOI: 10.7326/0003-4819-123-9-199511010-00005. View

Middelberg R, Spector T, Swaminathan R, Snieder H . Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins: effects of menopause. Arterioscler Thromb Vasc Biol. 2002; 22(7):1142-7. DOI: 10.1161/01.atv.0000022889.85440.79. View

Krotkiewski M . Thyroid hormones and treatment of obesity. Int J Obes Relat Metab Disord. 2000; 24 Suppl 2:S116-9. DOI: 10.1038/sj.ijo.0801294. View

Ritz P, Dumas J, Salle A, Simard G, Malthiery Y, Rohmer V . [Thyroid hormones and obesity]. Ann Endocrinol (Paris). 2002; 63(2 Pt 1):135-9. View

Bell A, Gagnon A, Grunder L, Parikh S, Smith T, Sorisky A . Functional TSH receptor in human abdominal preadipocytes and orbital fibroblasts. Am J Physiol Cell Physiol. 2000; 279(2):C335-40. DOI: 10.1152/ajpcell.2000.279.2.C335. View

Poehlman E, Toth M, Ades P, Rosen C . Menopause-associated changes in plasma lipids, insulin-like growth factor I and blood pressure: a longitudinal study. Eur J Clin Invest. 1997; 27(4):322-6. DOI: 10.1046/j.1365-2362.1997.1160662.x. View

Naslund E, Andersson I, Degerblad M, Kogner P, Kral J, Rossner S . Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men. J Intern Med. 2000; 248(4):299-308. DOI: 10.1046/j.1365-2796.2000.00737.x. View

10.

Schubert C, Rogers N, Remsberg K, Sun S, Chumlea W, Demerath E . Lipids, lipoproteins, lifestyle, adiposity and fat-free mass during middle age: the Fels Longitudinal Study. Int J Obes (Lond). 2005; 30(2):251-60. DOI: 10.1038/sj.ijo.0803129. View

11.

Ford E . Risks for all-cause mortality, cardiovascular disease, and diabetes associated with the metabolic syndrome: a summary of the evidence. Diabetes Care. 2005; 28(7):1769-78. DOI: 10.2337/diacare.28.7.1769. View

12.

Crawford S, Casey V, Avis N, McKinlay S . A longitudinal study of weight and the menopause transition: results from the Massachusetts Women's Health Study. Menopause. 2000; 7(2):96-104. DOI: 10.1097/00042192-200007020-00005. View

13.

Roti E, Minelli R, Salvi M . Thyroid hormone metabolism in obesity. Int J Obes Relat Metab Disord. 2000; 24 Suppl 2:S113-5. DOI: 10.1038/sj.ijo.0801293. View

14.

Bastemir M, Akin F, Alkis E, Kaptanoglu B . Obesity is associated with increased serum TSH level, independent of thyroid function. Swiss Med Wkly. 2007; 137(29-30):431-4. DOI: 10.4414/smw.2007.11774. View

15.

Valyasevi R, Harteneck D, Dutton C, Bahn R . Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts. J Clin Endocrinol Metab. 2002; 87(5):2352-8. DOI: 10.1210/jcem.87.5.8472. View

16.

Yamashita S, Nakamura T, Shimomura I, Nishida M, Yoshida S, Kotani K . Insulin resistance and body fat distribution. Diabetes Care. 1996; 19(3):287-91. DOI: 10.2337/diacare.19.3.287. View

17.

Sorisky A, Bell A, Gagnon A . TSH receptor in adipose cells. Horm Metab Res. 2001; 32(11-12):468-74. DOI: 10.1055/s-2007-978672. View

18.

Kannel W, Cupples L, Ramaswami R, Stokes 3rd J, Kreger B, Higgins M . Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol. 1991; 44(2):183-90. DOI: 10.1016/0895-4356(91)90265-b. View

19.

. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA. 2001; 285(19):2486-97. DOI: 10.1001/jama.285.19.2486. View

20.

Rexrode K, Carey V, Hennekens C, Walters E, Colditz G, Stampfer M . Abdominal adiposity and coronary heart disease in women. JAMA. 1998; 280(21):1843-8. DOI: 10.1001/jama.280.21.1843. View